United States

Amyotrophic Lateral Sclerosis Treatment Market to hit USD 1.1 billion by 2032, says Global Market Insights Inc.

Amyotrophic lateral sclerosis treatment industry is projected to witness a CAGR of 5.5% during the period 2024-2032. This growth can be attributed to the development of novel drug therapies.

Selbyville, Delaware, Oct. 24, 2024 (GLOBE NEWSWIRE) —

Amyotrophic Lateral Sclerosis (ALS) Treatment

Major players in amyotrophic lateral sclerosis treatment market include AB Science, Biogen Inc., Biohaven Pharmaceutical (Pfizer, Inc.), BrainStorm Therapeutics, Inc., Corestemchemon Inc., Eledon Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, Ionis Pharmaceuticals, Inc., ITF Pharma GmbH, Mitsubishi Tanabe Pharma Corporation, Otsuka America Pharmaceutical, Inc., and Sun Pharmaceutical Industries Ltd. among others.

Partial Table of Contents (ToC) of the report:

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Rising prevalence of amyotrophic lateral sclerosis (ALS) globally

3.2.1.2    Growing awareness and early diagnosis of ALS

3.2.1.3    Development of novel drug therapies

3.2.2    Industry pitfalls & challenges

3.2.2.1    High cost associated with treatment

3.2.2.2    Side effects associated with treatment

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Future market trends

3.6    Pipeline analysis

3.7    Porter’s analysis

3.8    PESTEL analysis

Browse more disease specific drugs industry reports @ https://www.gminsights.com/industry-reports/disease-specific-drugs/82

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

CONTACT: Contact Us:
Aashit Tiwari
Corporate Sales, USA
Global Market Insights Inc.
Toll Free: +1-888-689-0688
USA: +1-302-846-7766
Europe: +44-742-759-8484
APAC: +65-3129-7718
Email: [email protected]
Read More News @ https://ibmag.com

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker